Trial intelligence / Profile preview

FSH plus hCG for final oocyte maturation triggering in antagonist IVF cycles

IRCT20150310021420N5Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
May 2021
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, randomised, single-blind trial in female infertility comparing FSH + hCG trigger with hCG alone trigger (2 arms). Primary endpoint: Oocyte quality. Started May 2021; status: completed.

02

Drugs

follicle-stimulating hormonehuman chorionic gonadotropin
03

Conditions

female infertility

Beyond the preview

Go deeper on IRCT20150310021420N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20150310021420N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call